Scaled Biolabs ^Companies

Scaled Biolabs is an organization that focuses on accelerating the discovery and development of cell therapies. They utilize microfluidics, automation, and machine learning to create a Cell Therapy Discovery Engine. This engine allows biotech and pharma companies to analyze numerous parameters across thousands of experimental processes, providing valuable insights into cell-driven biology. Scaled Biolabs aims to simplify manufacturing, reduce time to market, and improve clinical outcomes for cell-based medicines. Additionally, they also develop their own cell therapy assets, including a program funded by CIRM that focuses on developing a curative cell therapy for Parkinson's disease using iPSC-derived dopaminergic neurons.